Age-related changes in P-glycoprotein expression in senescence-accelerated mouse

Current Aging Science

Volumn 2, Issue 3, 2009, Pages 187-192

  Wu, Bin ^a,b   Ueno, Masaki ^a   Onodera, Masayuki ^a   Kusaka, Takashi ^a   Huang, Cheng long ^a   Hosomi, Naohisa ^a   Kanenishi, Kenji ^a   Sakamoto, Haruhiko ^a  

^a KAGAWA UNIVERSITY   (Japan)

^b CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Abcb1a; Abcb1b; Blood brain barrier; Mdr1; P glycoprotein; SAM

Indexed keywords

GLYCOPROTEIN P; MULTIDRUG RESISTANCE PROTEIN 1; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN 3; P GLYCOPROTEIN 2; P-GLYCOPROTEIN 2;

AGING; ANIMAL EXPERIMENT; ARTICLE; BLOOD BRAIN BARRIER; CONTROLLED STUDY; GENE MUTATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SENESCENCE; ANIMAL; ANIMAL MODEL; ASTROCYTE; BRAIN; CELL AGING; ENDOTHELIUM CELL; GENE EXPRESSION REGULATION; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; MUTATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VASCULARIZATION; WESTERN BLOTTING;

ANIMALS; ASTROCYTES; BLOTTING, WESTERN; BRAIN; CELL AGING; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; MALE; MICE; MODELS, ANIMAL; MUTATION; P-GLYCOPROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 77649207086     PISSN: 18746098     EISSN: 18746128     Source Type: Journal    
DOI: 10.2174/1874609810902030187     Document Type: Article

References (38)

1. Takeda T, Hosokawa M, Takeshita S, Irino M, Higuchi K, Matsushita T, et al. A new murine model of accelerated senescence. Mech Ageing Dev 1981; 17: 183-94.
2. Takeda T, Hosokawa M and Higuchi K. Senescence-accelerated mouse (SAM): A novel murine model of accelerated senescence. J Am Geriatr Soc 1991; 39: 911-19.
3. Miyamoto M, Kiyota Y, Yamazaki N, Nagaoka A, Matsuo T, Nagawa Y, et al. Age-related change in learning and memory in the senescence-accelerated mouse (SAM). Physiol Behav 1986; 38: 399-406.
4. Ueno M, Akiguchi I, Yagi H, Naiki H, Fujibayashi Y, Kimura J, et al. Age-related changes in barrier function in mouse brain. I. Accelerated age-related increase of brain transfer of serum albumin in accelerated senescence prone SAM-P/8 mice with deficits in learning and memory. Arch Gerontol Geriatr 1993; 16: 233-48.
5. Ueno M, Akiguchi I, Hosokawa M, Shinnou M, Sakamoto H, Takemura M, et al. Ag-related changes in the brain transfer of blood-borne horseradish peroxidase in the hippocampus of senescence-accelerated mouse. Acta Neuropathol 1997; 93: 233-40.
6. Ueno M, Sakamoto H, Kanenishi K, Onodera M, Akiguchi I and Hosokawa M. Ultrastructural and permeability features of microvessels in the hippocampus, cerebellum and pons of senescence-accelerated mice (SAM). Neurobiol Aging 2001; 22: 469-78.
7. Pelegri C, Canudas AM, del Valle J, Casadesus G, Smith MA, Camins A, et al. Increased permeability of blood-brain barrier on the hippocampus of a murine model of senescence. Mech Ageing Dev 2007; 128: 522-28.
8. Banks WA, Farr SA and Morley JE. Permeability of the blood-brain barrier to albumin and insulin in the young and aged SAMP8 mouse. J Gerontol 2000; 55A: B601-06.
9. Takemura M, Nakamura S, Akiguchi I, Ueno M, Oka N, Ishikawa S, et al. β/A4 proteinlike immunoreactive granular structures in the brain of senescence-accelerated mouse. Am J Pathol 1993; 142: 1887-97.
10. Morley JE, Kumar VB, Bernardo AE, Farr SA, Uezu K, Tumosa N, et al. β-Amyloid precursor polypeptide in SAMP8 mice affects learning and memory. Peptides 2000; 21: 1761-67.
11. Tamai I, Yamashita J, Kido Y, Ohnari A, Sai Y, Shima Y, et al. Limited distribution of new quinolone antibacterial agents into brain caused by multiple efflux transporters at the blood-brain barrier. J Pharmacol Exp Ther 2000; 295: 146-52.
12. Ling V. P-glycoprotein: its role in drug resistance. Am J Med 1995; 99: 315-45.
13. Bodo A, Bakos B, Szeri F, Varadi A and Sarkadi B. The role of multidrug transporters in drug availability, metabolism and toxicity. Toxicol Lett 2003; 140-141: 133-43.
14. Fromm MF. Importance of P-glycoprotein for drug disposition in humans. Eur J Clin Invest 2003; 33: 6-9.
15. Schinkel AH and Jonker JW. Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overreview. Adv Drug Deliv Rev 2003; 55: 3-29.
16. Schinkel AH. P-glycoprotein, a gatekeeper in the blood-brain barrier. Adv Drug Deliv Rev 1999; 36: 179-94.
17. Lam FC, Liu R, Lu P, Shapiro AB, Renoir J-M, Sharom FJ, et al. β-Amyloid efflux mediated by p-glycoprotein. J Neurochem 2001; 76: 1121-28.
18. Vogelgesang S, Cascorbi I, Schroeder E, Pahnke J, Kroemer HK, Siegmund W, et al. Deposition of Alzheimer's β-amyloid is inversely correlated with P-glycoprotein expression in the brains of elderly non-demented humans. Pharmacogenetics 2002; 12: 535-41.
19. Devault A and Gros P. Two members of the mouse mdr gene family confer multidrug resistance with overlapping but distinct drug specificities. Mol Cell Biol 1990; 10: 1652-63.
20. Ambudkar SV, Kimchi-Sarfaty C, Sauna ZE and Gottesman MM. P-glycoprotein: from genomics to mechanism. Oncogene 2003; 22: 7468-85.
21. Sawicki WT, Kujawa M, Jankowska-Steifer E, Mystkowska ET, Hyc A and Kowalewski C. Temporal/spatial expression and efflux activity of ABC transporter, P-glycoprotein/Abcb1 isoforms and Bcrp/Abcg2 during early murine development. Gene Exp Patterns 2006; 6: 738-46.
22. Mason BL, Patriante CM and Thomas SA. A revised role for P-glycoprotein in the brain distribution of dexamethasone, cortisol, and corticosterone in wild type and ABCB1A/B-deficient mice. Endocrinology 2008; 149: 5244-53.
23. Schinkel AH, Mayer U, Wagenaar E, Mol CAAM, van Deemter L, Smit JM, et al. Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins. Proc Natl Acad Sci USA 1997; 94: 4028-33.
24. Regina A, Koman A, Piciotti M, El Hafny B, Center MS, Bergmann R, et al. Mrp1 multidrug resistance-associated protein and P-glycoprotein expression in rat brain microvessel endothelial cells. J Neurochem 1998; 71: 705-15.
25. Ueno M, Nakagawa T, Huang C, Ueki M, Kusaka T, Hosomi N, et al. The expression of P-glycoprotein is increased in vessels with blood-brain barrier impairment in a stroke-prone hypertensive model. Neuropathol Appl Neurobiol 2009; 35: 147-55.
26. Zhang G, Zhang B, Fu X, Tomozawa H, Matsumoto K, Higuchi K, et al. Senescence-Accelerated Mouse (SAM) strains have a spontaneous mutation in the Abcb1a gene. Exp Anim 2008; 57: 413-17.
27. Wu B, Ueno M, Kusaka T, Onodera M, Huang CN, Hosomi N, et al. Abcb1a and Abcb1b expression in senescence-accelerated mouse (SAM). Neurosci Lett 2009; 456: 34-38.
28. Huang C, Liu D, Kameyama K, Nakashima T, Yokomise H, Ueno M, et al. MRP-1/CD9 gene transduction downregulates Wnt signal pathways. Oncogene 2004; 23: 7475-83.
29. Deane R, Wu Z and Zlokovic BV. Rage (Yin) versus LRP (Yang) balance regulates Alzheimer amyloid -peptide clearance through transport across the blood-brain barrier. Stroke 2004; 35: 2628-31.
30. Donahue JE, Flaherty SL, Johanson CE, Duncan III JA, Silverberg GD, Miller MC, et al. RAGE, LRP-1, and amyloid-beta protein in Alzheimer's disease. Acta Neuropathol 2006; 112: 405-15.
31. Morley JE, Kumar VB, Bernardo AE, Farr SA, Uezu K, Tumosa N, et al. β-amyloid precursor polypeptide in SAMP8 mice affects learning and memory. Peptides 2000; 21: 1761-67.
32. Giri R, Shen Y, Stins M, Yan SD, Schmidt AM, Stern D, et al. β-amyloid-induced migration of monocytes across human brain endothelial cells involves RAGE and PECAM-1. Am J Physiol Cell Physiol 2000; 279: C1772-81.
33. Zlokovic BV, Yamada S, Hlozman D, Ghiso J and Frangione B. Clearance of amyloid -peptide from brain: transport or metabolism? Nat Med 2000; 6: 718-19.
34. Cirrito JR, Deane R, Fagan AM, Spinner ML, Parsadanian M, Finn MB, et al. P-glycoprotein deficiency at the blood-brain barrier increases amyloid-deposition in an Alzheimer disease mouse model. J Clin Invest 2005; 115: 3285-90.
35. Hartz AMS, Bauer B, Fricker G and Miller DS. Rapid modulation of P-glycoprotein-mediated transport at the blood-brain barrier by tumor necrosis factor-alpha and lipopolysaccharide. Mol Pharmacol 2006; 69: 462-70.
36. Salkeni MA, Lynch JL, Otamis-Price T and Banks WA. Lipopolysaccharide impairs blood-brain barrier P-glycoprotein function in mice through prostaglandin-and nitric oxide-independent pathways. J Neuroimmune Pharmacol 2009; 4(2): 276-82.
37. Schlachetzki F and Pardridge WM. P-glycoprotein and caveolin-1alpha in endothelium and astrocytes of primate brain. Neuroreport 2003; 14: 2041-46.
38. Bendayan R, Ronaldson PT, Gingras D and Bendayan M. In situ localization of P-glycoprotein (ABCB1) in human and rat brain. J Histochem Cytochem 2006; 54: 1159-67.